Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antitumor Activity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT06065059
What this trial is testing

Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumors

Who this might be right for
Breast CancerOvarian CancerPancreas Cancer+5 more
Tango Therapeutics, Inc. 7
Early research (Phase 1)Study completedNCT02795182
What this trial is testing

Zanubrutinib (BGB-3111) in Combination With Tislelizumab (BGB-A317) in Participants With B-cell Malignancies

Who this might be right for
LymphomaLeukemia
BeiGene 75
Testing effectiveness (Phase 2)Looking for participantsNCT07038343
What this trial is testing

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Who this might be right for
Solid Tumor CancerLocally AdvancedMetastatic Solid Tumors+5 more
Avenzo Therapeutics, Inc. 480
Early research (Phase 1)Looking for participantsNCT05981703
What this trial is testing

A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorSolid Tumor
BeOne Medicines 337
Testing effectiveness (Phase 2)Ended earlyNCT02034227
What this trial is testing

Safety, Tolerability Study of SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaChronic Lymphocytic Leukemia
Spirogen 6
Not applicableLooking for participantsNCT06999616
What this trial is testing

Physical Activity in Cancer Patients in an Oncology Day Clinic - Implementing a Person-centered Program Led by Nurses

Who this might be right for
NeoplasmsMotor ActivityChemotherapy+2 more
St.Gallen University of Applied Sciences 50
Early research (Phase 1)Ended earlyNCT05470933
What this trial is testing

A Study Explore WJ01075 Tablets in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Suzhou Junjing BioSciences Co., Ltd. 7
Early research (Phase 1)Study completedNCT05800249
What this trial is testing

PE0116 Injection in Treatment of Patients With Advanced Solid Tumours

Who this might be right for
Locally Advanced/Metastatic Solid Tumors
Shanghai HyaMab Biotech Co.,Ltd. 31
Testing effectiveness (Phase 2)Ended earlyNCT03860844
What this trial is testing

Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid Leukemia
Sanofi 67
Early research (Phase 1)Active Not RecruitingNCT06057038
What this trial is testing

A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors

Who this might be right for
Malignant Solid Tumor
Genmab 8
Early research (Phase 1)Looking for participantsNCT07141706
What this trial is testing

DB-1317 in Selected Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced/Metastatic Solid Tumors
DualityBio Inc. 253
Early research (Phase 1)Active Not RecruitingNCT05621486
What this trial is testing

A Clinical Study to Evaluate B4T2-001 CAR T Cells in the Treatment of Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Shanghai East Hospital 36
Early research (Phase 1)Study completedNCT04881045
What this trial is testing

Study to Test the Safety and Tolerability of PF-07257876 in Participants With Selected Advanced Tumors.

Who this might be right for
Non-Small Cell Lung CancerSquamous Cell Carcinoma of the Head and NeckOvarian Cancer
Pfizer 29
Early research (Phase 1)Looking for participantsNCT06428331
What this trial is testing

SKB518 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07742956
What this trial is testing

Phase II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of ALK201 for Injection in Combination With Ivonescimab Injection in sqNSCLC Participants.

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)
Shanghai Allink Biotherapeutics Co., Ltd. 156
Testing effectiveness (Phase 2)Ended earlyNCT05497453
What this trial is testing

Evaluate OTX-2002 in Patients with Hepatocellular Carcinoma and Other Solid Tumor Types Known for Association with the MYC Oncogene

Who this might be right for
Hepatocellular CarcinomaSolid TumorHepatocellular Carcinoma Non-resectable+4 more
Omega Therapeutics 24
Early research (Phase 1)Ended earlyNCT06779851
What this trial is testing

Evaluate Safety and Tolerability of BPT567 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bright Peak Therapeutics Inc 20
Early research (Phase 1)Not Yet RecruitingNCT07583914
What this trial is testing

Safety, Tolerability, and Preliminary Antitumor Activity of Non-Cationic Peptide-CD47 siRNA in Advanced Solid Tumors

Who this might be right for
Solid Tumor CancerMetastasesHead and Neck Cancer
West China Hospital 9
Early research (Phase 1)WithdrawnNCT00538096
What this trial is testing

A Phase I Study to Evaluate Safety, Tolerability in Adults With Lymphoma

Who this might be right for
Lymphoma, B-CellLymphoma, Non-Hodgkin
MedImmune LLC 18
Early research (Phase 1)Study completedNCT02669017
What this trial is testing

Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL)

Who this might be right for
Non-Hodgkin LymphomaBurkitt's LymphomaChronic Lymphocytic Leukemia+6 more
ADC Therapeutics S.A. 183
Next Page